feed,title,long_url,short_url
Barron's,"Biogen Is Still a Buy Despite Alzheimer's Drug Concerns, Analyst Says",https://www.barrons.com/articles/biogen-is-still-a-buy-despite-alzheimers-drug-concerns-analyst-says-51626704363?mod=RTA,https://j.mp/3hO44CE
